Article

Thirteen-fold variation between states in clozapine prescriptions to United States Medicaid patients

2022-04-04

Abstract excerpt

<h4>Background</h4> Clozapine was the first atypical antipsychotic for treating schizophrenia, with a long history of controversy over its usage. Guidelines currently recommend clozapine for patients diagnosed with refractory schizophrenia. However, this agent may be underutilized because of the costs associated with close monitoring of its adverse effects, particularly agranulocytosis. This is unfortunate because...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2db58b9e-01fe-5f13-bd18-853e6eaf110d
DOI: 10.1101/2022.04.03.22273352

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Thirteen-fold variation between states in clozapine prescriptions to United States Medicaid patientsDOI 10.1101/2022.04.03.22273352Read

Prescribing trends for the same patients with schizophrenia over 20 yearsSemantic proximity Read

Assessing demographic and clinical characteristics and healthcare resource utilization of patients with schizophrenia with inadequate response to antipsychotic treatmentSemantic proximity Read

Prescribing trends in psychotropic medications among outpatients of a Latin American Healthcare setting: a five-year retrospective studySemantic proximity Read

Trends in Prescriptions of Lithium and Other Medications for Patients with Bipolar Disorder in Office-based Practices in the United States: 1996-2015Semantic proximity Read

Antipsychotic polypharmacy and clozapine prescribing patterns: evolution and correlates before and after a psychiatric hospitalisationSemantic proximity Read

Clozapine efficacy and adverse drug reactions among a nationwide study of 1021 Australians prescribed clozapine: The ClozaGene StudySemantic proximity Read

Racial Disparities in Antipsychotic Prescribing among Foster Youth: A Single Institution StudySemantic proximity Read

Clozapine: An Updated Overview of Pharmacogenetic Biomarkers, Risks, and Safety—Particularities in the Context of COVID-19Semantic proximity Read

Clozapine: An Updated Overview of Pharmacogenetic Biomarkers, Risks, and Safety—Particularities in the Context of COVID-19Semantic proximity Read

Psychotropic drugs in Portugal from 2016 to 2019: a nationwide pharmacoepidemiological profileSemantic proximity Read

Links between the amount of antipsychotic medication prescribed per population at general practice level, local demographic factors and medication selectionSemantic proximity Read

PS1-37: Comparison of Antipsychotic Polypharmacy Trends among Schizophrenia Patients across Multiple Healthcare SystemsSemantic proximity Read